The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
fbV6g2DEj7daL60Z
